|
| 37669770 | Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims. | Pharmacoepidemiol Drug Saf | 2024 |
| 37669770 | Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims. | Pharmacoepidemiol Drug Saf | 2024 |
| 35976191 | Identification of pregnancies in healthcare data: A changing landscape. | Pharmacoepidemiol Drug Saf | 2023 |
| 35976191 | Identification of pregnancies in healthcare data: A changing landscape. | Pharmacoepidemiol Drug Saf | 2023 |
| 37067897 | Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: Informing gestational age assumptions when clinical estimates are not available. | Pharmacoepidemiol Drug Saf | 2023 |
| 37067897 | Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: Informing gestational age assumptions when clinical estimates are not available. | Pharmacoepidemiol Drug Saf | 2023 |
| 34498338 | Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications? | Pharmacoepidemiol Drug Saf | 2022 |
| 34498338 | Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications? | Pharmacoepidemiol Drug Saf | 2022 |
| 33091194 | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. | Pharmacoepidemiol Drug Saf | 2021 |
| 33591859 | A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. | Curr Med Res Opin | 2021 |
| 34172693 | Improving the Quality of Observational Data: Registries of Validated Outcomes and Other Patient Events. | Epidemiology | 2021 |
| 34082800 | Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis. | Orphanet J Rare Dis | 2021 |
| 33091194 | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom. | Pharmacoepidemiol Drug Saf | 2021 |
| 33591859 | A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. | Curr Med Res Opin | 2021 |
| 34172693 | Improving the Quality of Observational Data: Registries of Validated Outcomes and Other Patient Events. | Epidemiology | 2021 |
| 34082800 | Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis. | Orphanet J Rare Dis | 2021 |
| 32864627 | Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. | Lancet Rheumatol | 2020 |
| 33374185 | The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. | Viruses | 2020 |
| 32864627 | Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. | Lancet Rheumatol | 2020 |
| 33374185 | The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. | Viruses | 2020 |
| 30489349 | Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder. | Epidemiology | 2019 |
| 30489349 | Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder. | Epidemiology | 2019 |
| 31381574 | Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth. | PLoS One | 2019 |
| 31381574 | Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth. | PLoS One | 2019 |
| 29135571 | Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. | Epidemiology | 2018 |
| 30260993 | Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. | PLoS One | 2018 |
| 29723926 | Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study. | Pharmacotherapy | 2018 |
| 29135571 | Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. | Epidemiology | 2018 |
| 29134254 | Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study. | Eur J Clin Pharmacol | 2018 |
| 29345103 | Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study. | Basic Clin Pharmacol Toxicol | 2018 |
| 29794511 | Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. | Epidemiology | 2018 |
| 30260993 | Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. | PLoS One | 2018 |
| 29723926 | Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study. | Pharmacotherapy | 2018 |
| 29794511 | Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. | Epidemiology | 2018 |
| 29134254 | Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study. | Eur J Clin Pharmacol | 2018 |
| 29345103 | Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study. | Basic Clin Pharmacol Toxicol | 2018 |
| 28604563 | Risk Factors for RSV Hospitalization in Healthy Preterm Infants: A Meta-analysis. | Pediatr Infect Dis J | 2017 |
| 28866800 | Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States. | Infect Dis Ther | 2017 |
| 28604563 | Risk Factors for RSV Hospitalization in Healthy Preterm Infants: A Meta-analysis. | Pediatr Infect Dis J | 2017 |
| 28759401 | The Safety of Medications in Pregnant Women: An Opportunity to Use Database Studies. | Pediatrics | 2017 |
| 28756575 | Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis. | Drugs Real World Outcomes | 2017 |
| 28493461 | Ophthalmic nepafenac use in the Netherlands and Denmark. | Acta Ophthalmol | 2017 |
| 28370075 | Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. | Pharmacotherapy | 2017 |
| 28493461 | Ophthalmic nepafenac use in the Netherlands and Denmark. | Acta Ophthalmol | 2017 |
| 28370075 | Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. | Pharmacotherapy | 2017 |
| 28756575 | Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis. | Drugs Real World Outcomes | 2017 |
| 28866800 | Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States. | Infect Dis Ther | 2017 |
| 28759401 | The Safety of Medications in Pregnant Women: An Opportunity to Use Database Studies. | Pediatrics | 2017 |
| 26769243 | Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies. | BMC Cardiovasc Disord | 2016 |
| 27093166 | Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review. | Pediatr Infect Dis J | 2016 |